Several newly generated mouse embryonic stem (ES) cell lines were tested for their ability to produce completely ES cell-derived mice at early passage numbers by ES cell * tetraploid embryo aggregation. One line, designated Rl, produced live offspring which were completely ES cellderived as judged by isoenzyme analysis and coat color. These cell culture-derived anhnas were normal, viable, and fertile. However, prolonged in vitro culture negatively affected this initial totipotency of Rl, and after passage 14, ES cell-derived newborns died at birth. However, one of the five subclones (R1-S3) derived from single cells at passage 12 retained the oiginal totipotency and gave rise to viable, completely ES cell-derived animals. The (Nunc). Most embryos hatched and attached to the feeders by day 2 after plating. The inner cell masses (ICMs) were left to grow for 4 more days, when they were mechanically disaggregated in their own wells by using drawn-out Pasteur pipettes. Four to five days later, the cells were transferred into new wells either by trypsinizing or by mechanically disaggregating the undifferentiated colonies. We started counting passage number when we were first able to pass the cells into 35-mm plates (passage 1). The cells were first frozen at passage 5, which was "'3 weeks after the blastocyst stage. Four cell lines were established, designated Rl, R2, R6, and R13.
(R1-S3) derived from single cells at passage 12 retained the oiginal totipotency and gave rise to viable, completely ES cell-derived animals. The total in vitro culture time of the sublines at the time of testing was equivalent to passage 24 of the original line. Fully potent early passage Rl cells and the R1-S3 subclone should be very useful not only for ES cell-based genetic manipulations but also in defining opthnal in vitro culture conditions for retahinng the initial totipotency of ES cells.
Embryonic stem (ES) cells are now widely used for introducing targeted mutations and other genetic alterations into the mouse germ line (1, 2) . One of the basic requirements for the successful application of these new techniques is to maintain ES cell lines in a state compatible with germ-cell formation, when the cells are introduced back into a host embryo. Germ-line contribution is most likely to occur when cells retain broad developmental potential, contributing extensively to a wide variety of somatic tissues. We have recently developed a system to characterize the full developmental potential of ES cells (3) ; the system is based on aggregation of ES cells with developmentally compromised tetraploid embryos. In such chimeras the tetraploid component is selected against in all lineages where ES cells are able to differentiate normally, allowing the ES cells to take over the embryo proper and relegating the tetraploid component to the extraembryonic membranes.
We tested the developmental potential of several commonly used ES cell lines, such as D3 (4) and AB1 (5) , in this system and found that they were able to support fetal development up to term. However, all such completely ES cell-derived newborns died perinatally (3, 6) . To *To whom reprint and cell line requests should be addressed. bottom of the culture plate (3). The aggregates were cultured overnight in microdrops of M16 before transfer into the uterus of 2.5-day pseudopregnant recipients. Caesarean Section and Data Collection. Pregnant recipients were routinely subject to a Caesarean section on day 18.5 of pregnancy. Live fetuses were counted as well as the number ofearly postimplantation resorptions and embryos dying at or after midgestation. Fetuses that were alive at delivery but failed to survive the early postnatal period were subject to complete glucose phosphate isomerase (GPI) analysis. Fetuses that recovered after the Caesarean section were placed with foster mothers, and a small sample of blood and the tip of the tail were taken for GPI analysis. Adult ES cell-derived mice were mated with CD1 females to test for germ-line transmission. After test breeding, two mice were killed and various tissues were dissected for GPI analysis.
Genetic Markers. The polymorphic Gpi-l gene was used to distinguish between the tetraploid embryo and ES cellderived components of the chimeras; the ES cell lines were derived from GPI-AA 129 and the tetraploid components were produced from GPI-BB CD-1 embryos. The isoenzyme analysis was performed as described earlier (11 (13) . Differentiation capabilities and developmental potential of cells at passage 6-8 were tested in vitro by differentiating the cells into embryoid bodies (4) or in vivo by aggregating them with tetraploid embryos (3). All of them developed cystic embryoid bodies at similar frequency in vitro (data not shown). However, their in vivo developmental potential showed differences (Table 1) . R2 and R6 were not able to support development to term. Recipients containing R6 chimeras had only signs that implantation occurred, but no remnants of either fetus or decidual tissue remained. Two of 37 R13-tetraploid embryo aggregates developed to term. Both were completely R13-derived as judged by GPI assay of their main organs. They had extremely high birth weight (ca. 3g) and swollen edemic skin. They failed to oxygenize their lungs and died shortly after birth. No detailed pathology was performed. The nine newborns from Rl-tetraploid embryo aggregates showed no sign of apparent anatomical abnormalities, although only three ofthem recovered from Cesarean section. Two of these three reached adulthood. GPI assay of their blood and tail indicated pure Ri origin of one of the survivors. However, the other had about 10-15% tetraploid contribution (data not shown).
Southern blot analysis of the DNA (Fig. 1 ) prepared from Ri, R2, R6, and R13 with a Y chromosome-specific probe (12) Aggregates with tetraploid embryos were prepared by using cells from passages 6-24. Raw data on the prenatal and perinatal development ofthese aggregates are shown in Table  2 . There was no obvious difference between the different culture conditions in their ability to support development to term. Thus, to obtain a clear idea on the effect of in vitro culture time on developmental potential, data from the three culture conditions were pooled into two age groups: early (6-14) and late passages (Table 3) (Fig. 2) , but the modal number was still 40.
Characterization of Completely ES Cell-Derived Animals. Since the tetraploid component was produced from albino and preselected GPI-BB CD1 embryos and Ri was agouti and GPI-AA, both the coat color and the GPI served as markers to detect occasional tetraploid contribution in the animals derived from Rl-tetraploid embryo aggregates. The coat color of all five animals indicated only agouti contribution (Fig. 3) . However, GPI analysis of blood from adult animals showed that one animal contained detectable tetraploid contribution (ca. 5-10%o). This animal was the same one showing tetraploid contribution at birth. The remaining four animals showed no evidence of tetraploid cells in the blood. Further, GPI assay of the organs of two of the five animals-analyzed at 10 months of age-showed exclusive Ri contribution (Fig.  4 shows one of the two analyzed). Thus, within the limits of sensitivity of the GPI analysis, which allowed detection of contributions as low as 2%, no tetraploid cells remained in these animals. A minor contribution (<2%) from tetraploid cells cannot be excluded. The remaining three animals are more than 1 year old. They do not show any signs of premature aging or tumor development. It is likely that the life span of completely ES-derived animals is not affected by their cell culture origin.
The two newborns derived from R13 were female as predicted from Southern blot analysis of the cell line. Nearly all of the completely Ri-derived newborns were male as predicted. However, two ofthese total 32 newborns (Table 3) were female. One of these two newborns reached adulthood but was not fertile. The existence of an Rl-derived female may indicate some degree of Y chromosome loss in this cell line even at this early passage number. Y-chromosome loss could not have been complete, Southern blot analysis showed Y-specific sequences in this animal (Fig. 4) . To test the two models, we established subclones from single cells of passage 12 by using the original culture conditions and maintained them in vitro for a period equivalent to that of passage 24-25 of the original Rl stock before testing for pluripotency by tetraploid embryo aggregation. 
